Willis Towers Watson
WTW
290.67
-1.31
-0.45%
Willis Towers Watson
US · WTW
#736 by market cap
Listed 1970
290.67
-1.31
-0.45%
Live - 5344 symbols - heartbeat 481s ago
· 2026-10-08 04:00
Pre-market
290.67
0.00%
After-hours
290.67
0.00%
Overnight
288.50
-0.75%
- Market cap
- 27.00B
- P/E (TTM)i
- 18.00
- P/Bi
- 3.51
- EPSi
- 16.26
- Div yieldi
- 1.29%
- 52W posi
- 46%
Reader sentiment
Are you bullish or bearish on WTW?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Accumulating
- The number of reporting institutions decreased by 3 in the most recent period (2026/Q3).
- Total institutional ownership rose 0.1 percentage points.
Institutional ownership
- Held by institutions
- 101.83% +0.12pp
- Institutions
- 877 -3
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions added shares last reporting period, and the stock has seen net inflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund92.25%
Hedge Fund2.35%
Public Company2.08%
Government Pension Fund1.71%
Sovereign Wealth Fund1.60%
Private Company1.14%
Individual/Insider0.36%
Insurance Company0.28%
VC/PE Fund0.12%
Top holders as of 2026-06-30
BlackRock
8.95% · 8.31M sh
Dodge & Cox
8.64% · 8.03M sh
Vanguard Capital Management, LLC
7.22% · 6.70M sh
Harris Associates L.P.
6.36% · 5.91M sh
Artisan Partners Limited Partnership
5.97% · 5.54M sh
MFS Investment Management
5.91% · 5.49M sh
First Eagle Investment Management, LLC
4.82% · 4.48M sh
State Street Global Advisors
4.65% · 4.32M sh
Vanguard Portfolio Management, LLC
4.38% · 4.06M sh
Geode Capital Management, LLC
2.80% · 2.60M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 39 buys · 10 sells
| Name | Role | Stake |
|---|---|---|
| Carl Hess | Chief Executive Officer | 0.11% |
| Julie Gebauer | Global Head of Health, Wealth & Career | 0.08% |
| Matthew Furman | General Counsel | 0.04% |
| Andrew Krasner | Chief Financial Officer | 0.03% |
| Anne Pullum | Head of Europe | 0.02% |
| Paul Thomas | Independent Non-Executive Chair of the Board | 0.01% |
| Kristy Banas | Chief Human Resources Officer | 0.01% |
| Alexis Faber | Chief Operating Officer | 0.01% |
| Lucy Clarke | President of Risk & Broking | 0.01% |
| Imran Qureshi | MD & Head of North America | 0.01% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-30 | Lucy Clarke | President of Risk & Broking | Sale to Issuer | -1,916 | $288.23 |
| 2026-08-12 | Carl Hess | Chief Executive Officer | Other Derivative Acquisition | +53 | -- |
| 2026-08-12 | Julie Gebauer | Global Head of Health, Wealth & Career | Other Derivative Acquisition | +12 | -- |
| 2026-08-12 | Andrew Krasner | Chief Financial Officer | Other Derivative Acquisition | +4 | -- |
| 2026-08-09 | Alexis Faber | Chief Operating Officer | Open Market Disposition | -730 | $342.70 |
| 2026-07-14 | Carl Hess | Chief Executive Officer | Other Acquisition | +51 | -- |
| 2026-07-14 | Carl Hess | Chief Executive Officer | Other Derivative Acquisition | +63 | -- |
| 2026-07-14 | Matthew Furman | General Counsel | Other Acquisition | +6 | -- |
| 2026-07-14 | Matthew Furman | General Counsel | Other Derivative Acquisition | +20 | -- |
| 2026-07-14 | Julie Gebauer | Global Head of Health, Wealth & Career | Other Acquisition | +11 | -- |
| 2026-07-14 | Julie Gebauer | Global Head of Health, Wealth & Career | Other Derivative Acquisition | +101 | -- |
| 2026-07-14 | Anne Pullum | Head of Europe | Other Acquisition | +6 | -- |
| 2026-07-14 | Anne Pullum | Head of Europe | Other Derivative Acquisition | +11 | -- |
| 2026-07-14 | Imran Qureshi | MD & Head of North America | Other Acquisition | +6 | -- |
| 2026-07-14 | Imran Qureshi | MD & Head of North America | Other Derivative Acquisition | +16 | -- |
| 2026-07-14 | Alexis Faber | Chief Operating Officer | Other Acquisition | +5 | -- |
| 2026-07-14 | Alexis Faber | Chief Operating Officer | Other Derivative Acquisition | +12 | -- |
| 2026-07-14 | Andrew Krasner | Chief Financial Officer | Other Acquisition | +15 | -- |
| 2026-07-14 | Andrew Krasner | Chief Financial Officer | Other Derivative Acquisition | +11 | -- |
| 2026-07-14 | Lucy Clarke | President of Risk & Broking | Other Acquisition | +41 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 04:00:02 · For reference only, not investment advice and not tailored to your situation.